Report cover image

Hypertension Drugs Market Size 2024-2032: Global Industry Analysis and Forecast

Publisher Acumen Research and Consulting
Published Jun 01, 2024
Length 250 Pages
SKU # ACRC19838270

Description

The Hypertension Drugs Market Size accounted for USD 26.5 Billion in 2023 and is estimated to achieve a market size of USD 38.3 Billion by 2032 growing at a CAGR of 4.2% from 2024 to 2032.

Hypertension, commonly known as high blood pressure, affects a significant portion of the global population and remains a leading cause of cardiovascular diseases, stroke, and kidney failure. As the prevalence of hypertension continues to rise due to factors such as an aging population, sedentary lifestyles, poor dietary habits, and increased stress, the demand for effective antihypertensive drugs is expanding. The hypertension drugs market encompasses a broad spectrum of pharmaceutical products aimed at managing and treating high blood pressure, improving patients' quality of life, and reducing the associated risks of long-term complications. This abstract provides a comprehensive overview of the hypertension drugs market, including market trends, segmentation, growth drivers, challenges, and key players.

Hypertension Drugs Market Segmentation

The worldwide market for hypertension drugs is split based on product type, condition, medication type, distribution channel, and geography.

Hypertension Drugs Market By Product Type

Diuretics
Beta blockers
Calcium Channel Blockers
Angiotensin-Converting Enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasodilators
Renin Inhibitors
Alpha-Blockers
Others

Hypertension Drugs Market By Condition

Primary Hypertension
Secondary Hypertension

Hypertension Drugs Medication Types

Monotherapy
Combination Therapy
Fixed Dose Combinations

Hypertension Drugs Market By Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Hypertension Drugs Market Regional Outlook

North America

U.S.
Canada

Europe

U.K.
Germany
France
Spain
Rest of Europe

Asia-Pacific

India
Japan
China
Australia
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Rest of Latin America

The Middle East & Africa

South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Hypertension Drugs Market Players

Some of the top hypertension drugs companies offered in our report includes Lupin, Bayer AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., GSK Plc, Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd, Zydus Group, and Fresenius Kabi AG.

Table of Contents

250 Pages
CHAPTER 1. Industry Overview of Hypertension Drugs Market
1.1. Definition and Scope
1.2. Summary
CHAPTER 2. Research Approach
2.1. Methodology
2.2. Data Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.2. Restraints and Challenges
3.3. Growth Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Market Concentration Ratio and Market Maturity Analysis of Hypertension Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Hypertension Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Hypertension Drugs Market By Product Type
5.1. Introduction
5.2. Hypertension Drugs Revenue By Product Type
5.2.1. Hypertension Drugs Revenue (USD Million) and Forecast, By Product Type, 2020-2032
5.2.2. Diuretics
5.2.2.1. Diuretics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Beta blockers
5.2.3.1. Beta blockers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Calcium Channel Blockers
5.2.4.1. Calcium Channel Blockers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Angiotensin-Converting Enzyme (ACE) Inhibitors
5.2.5.1. Angiotensin-Converting Enzyme (ACE) Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Angiotensin II Receptor Blockers (ARBs)
5.2.6.1. Angiotensin II Receptor Blockers (ARBs) Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.7. Vasodilators
5.2.7.1. Vasodilators Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.8. Renin Inhibitors
5.2.8.1. Renin Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.9. Alpha-Blockers
5.2.9.1. Alpha-Blockers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.10. Others
5.2.10.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Hypertension Drugs Market By Condition
6.1. Introduction
6.2. Hypertension Drugs Revenue By Condition
6.2.1. Hypertension Drugs Revenue (USD Million) and Forecast, By Condition, 2020-2032
6.2.2. Primary Hypertension
6.2.2.1. Primary Hypertension Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Secondary Hypertension
6.2.3.1. Secondary Hypertension Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Hypertension Drugs Market By Medication Type
7.1. Introduction
7.2. Hypertension Drugs Revenue By Medication Type
7.2.1. Hypertension Drugs Revenue (USD Million) and Forecast, By Medication Type, 2020-2032
7.2.2. Monotherapy
7.2.2.1. Monotherapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Combination Therapy
7.2.3.1. Combination Therapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Fixed Dose Combinations
7.2.4.1. Fixed Dose Combinations Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Hypertension Drugs Market By Distribution Channel
8.1. Introduction
8.2. Hypertension Drugs Revenue By Distribution Channel
8.2.1. Hypertension Drugs Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032
8.2.2. Retail Pharmacies
8.2.2.1. Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Hospital Pharmacies
8.2.3.1. Hospital Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Online Pharmacies
8.2.4.1. Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Hypertension Drugs Market By Country
9.1. North America Hypertension Drugs Market Overview
9.2. U.S.
9.2.1. U.S. Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
9.2.2. U.S. Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
9.2.3. U.S. Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
9.2.4. U.S. Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.3. Canada
9.3.1. Canada Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
9.3.2. Canada Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
9.3.3. Canada Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
9.3.4. Canada Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Hypertension Drugs Market By Country
10.1. Europe Hypertension Drugs Market Overview
10.2. U.K.
10.2.1. U.K. Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
10.2.2. U.K. Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
10.2.3. U.K. Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
10.2.4. U.K. Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.3. Germany
10.3.1. Germany Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
10.3.2. Germany Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
10.3.3. Germany Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
10.3.4. Germany Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.4. France
10.4.1. France Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
10.4.2. France Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
10.4.3. France Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
10.4.4. France Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.5. Spain
10.5.1. Spain Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
10.5.2. Spain Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
10.5.3. Spain Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
10.5.4. Spain Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
10.6.2. Rest of Europe Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
10.6.3. Rest of Europe Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
10.6.4. Rest of Europe Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Hypertension Drugs Market By Country
11.1. Asia Pacific Hypertension Drugs Market Overview
11.2. China
11.2.1. China Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
11.2.2. China Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
11.2.3. China Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
11.2.4. China Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.3. Japan
11.3.1. Japan Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
11.3.2. Japan Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
11.3.3. Japan Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
11.3.4. Japan Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.4. India
11.4.1. India Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
11.4.2. India Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
11.4.3. India Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
11.4.4. India Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.5. Australia
11.5.1. Australia Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
11.5.2. Australia Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
11.5.3. Australia Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
11.5.4. Australia Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.6. South Korea
11.6.1. South Korea Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
11.6.2. South Korea Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
11.6.3. South Korea Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
11.6.4. South Korea Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
11.7.2. Rest of Asia-Pacific Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
11.7.3. Rest of Asia-Pacific Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
11.7.4. Rest of Asia-Pacific Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Hypertension Drugs Market By Country
12.1. Latin America Hypertension Drugs Market Overview
12.2. Brazil
12.2.1. Brazil Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
12.2.2. Brazil Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
12.2.3. Brazil Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
12.2.4. Brazil Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.3. Mexico
12.3.1. Mexico Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
12.3.2. Mexico Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
12.3.3. Mexico Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
12.3.4. Mexico Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
12.4.2. Rest of Latin America Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
12.4.3. Rest of Latin America Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
12.4.4. Rest of Latin America Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Hypertension Drugs Market By Country
13.1. Middle East & Africa Hypertension Drugs Market Overview
13.2. GCC
13.2.1. GCC Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
13.2.2. GCC Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
13.2.3. GCC Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
13.2.4. GCC Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.3. South Africa
13.3.1. South Africa Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
13.3.2. South Africa Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
13.3.3. South Africa Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
13.3.4. South Africa Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Hypertension Drugs Revenue (USD Million) and Forecast By Condition, 2020-2032
13.4.2. Rest of Middle East & Africa Hypertension Drugs Revenue (USD Million) and Forecast By Product Type, 2020-2032
13.4.3. Rest of Middle East & Africa Hypertension Drugs Revenue (USD Million) and Forecast By Medication Type, 2020-2032
13.4.4. Rest of Middle East & Africa Hypertension Drugs Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Hypertension Drugs Market
14.1. Hypertension Drugs Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Hypertension Drugs Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Lupin
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2023
15.1.3.2. Lupin 2023 Hypertension Drugs Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Bayer AG
15.3. Teva Pharmaceutical Industries Ltd.
15.4. Pfizer Inc.
15.5. GSK Plc
15.6. Mylan N.V.
15.7. Novartis AG
15.8. Sun Pharmaceutical Industries Ltd.
15.9. F. Hoffmann-La Roche Ltd.
15.10. Zydus Group
15.11. Fresenius Kabi AG

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us